Regeneration of renal epithelial cells from metanephric mesenchymal cells
Regeneration of renal epithelial cells from metanephric mesenchymal cells
批准号:
14570772
负责人:
AWAZU Midori
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
bFGF和LIF孵育大鼠后肾间充质细胞诱导上皮细胞标记物E-cadherin的表达。阻断ERK不影响E-cadherin的表达,阻断p38则抑制E-cadherin的表达。为了鉴定介导p38作用的基因,我们使用cDNA微阵列分析了在p38抑制剂下培养的后肾中的基因表达模式。在p38抑制剂下调的基因中,我们发现了一个信号分子受体样蛋白酪氨酸磷酸酶K(RPTPκ)。RPTPκ属于受体样酪氨酸磷酸酶家族,与细胞粘附和增殖有关。RPTPκ在肾脏发育过程中的蛋白表达与p38的蛋白表达相同,并且被p38抑制剂抑制。PCNA阳性细胞在胚胎第14 ~ 25周的囊肿上皮中可见。而ERK在细胞内表达, ...更多信息 在对照组和pcy小鼠的肾小管中,在囊肿上皮细胞中观察到较强的免疫染色。磷酸化ERK仅在pcy小鼠中检测到,主要定位于囊肿中。p38在对照组中出生后不再表达,但在所检查的所有阶段的pcy小鼠的囊肿上皮中检测到。JNK在新生儿7天后在对照组的所有肾小管节段中表达。相比之下,肾小管和囊肿的pcy肾表达很少JNK。给6周龄的pcy小鼠腹膜内施用MEK抑制剂PD 98059持续4周显著降低了水摄入量,增加了尿渗透压,并抑制了囊肿形成。结论:在pcy小鼠囊肿上皮中,ERK、磷酸化ERK和p38的表达上调,JNK的表达下调。抑制ERK的表达可抑制囊肿的形成,减轻尿浓缩缺陷。这些结果提示MAPKs尤其是ERK的异常调节在多囊肾病的病理生理过程中可能起重要作用,并可能成为一个新的治疗靶点。少
英文摘要
Incubation of rat metanephric mesenchymal cells with bFGF and LIF induced expression of an epithelial cell marker E-cadherin. The expression of E-cadherin was not affected by the blockade of ERK, but was suppressed by the blockade of p38. To identify genes that mediate the effect of p38, we analyzed patterns of gene expression in metanephroi cultured under a p38 inhibitor using CDNA microarray. Among downregulated genes by a p38 inhibitor, we found a signaling molecule receptor-like protein tyrosine phosphatase k (RPTPκ). RPTPκ belongs to the family of receptor-like tyrosine phosphatases and is implicated in cell adhesion and proliferation. The protein expression of RPTPκ during kidney development was identical to that of p38, and suppressed by a p38 inhibitor.We next investigated the expression of MAP kinases in a murine model of polycystic kidney disease pcy mice. PCNA-positive cells were recognized in cyst epithelia from embryonic day 14 to 25 weeks of age. While ERK was expressed i … More n tubules of kidneys from control and pcy mice, stronger immunostaining was observed in cyst epithelia. Phosphorylated ERK was detected only in pcy mice localizing predominantly in cysts. p38 was no longer expressed after birth in controls, but was detected in cyst epithelia of pcy mice at all stages examined. JNK was expressed in all tubular segments of controls after neonatal day 7. In contrast, tubules and cysts of pcy kidneys expressed little JNK. Administration of a MEK inhibitor PD98059 to 6-week old pcy mice intraperitoneally for 4 weeks significantly decreased water intake, increased urine osmolality, and suppressed cyst formation. In conclusion, the expression of ERK, phosphorylated ERK, and p38 were upregulated, and that of JNK was downregulated in cyst epithelia of pcy mice. The inhibition of ERK suppressed cyst formation and alleviated the urinary concentrating defect. These resuks suggest that dysregulation of MAPKs, especially that of ERK, may play an important role in the pathophysiology of polycystic kidney disease and could be a novel therapeutic target. Less
期刊论文(152)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
培養尿管芽細胞周期的伸展刺激によるアポトーシス誘導-P38、ERKの役割-.
通过周期性拉伸刺激培养的输尿管母细胞诱导细胞凋亡 - P38 和 ERK 的作用。
DOI:
--
发表时间:
2005
期刊:
日本腎臓学会誌 (印刷中)
影响因子:
--
作者:
[藤田尚代, 大森さゆ, 飛彈麻里子, 福田恵一, 長田道夫, 粟津緑]
通讯作者:
粟津緑
Receptor-like protein tyrosine phosphataseκ mediates the signaling of p38 mitogen-activated protein kinase during rat renal development.
受体样蛋白酪氨酸磷酸酶κ在大鼠肾脏发育过程中介导p38丝裂原激活蛋白激酶的信号传导。
DOI:
--
发表时间:
2004
期刊:
J.Am.Soc.Nephrol. 15
影响因子:
--
作者:
[Hida, M. et al.]
通讯作者:
M. et al.
Stretch induces apoptosis via ERK and p38 in a ureteric bud cell line.
拉伸通过 ERK 和 p38 在输尿管芽细胞系中诱导细胞凋亡。
DOI:
--
发表时间:
2004
期刊:
J.Am.Soc.Nephrol. 15
影响因子:
--
作者:
[Fujita, H. et al.]
通讯作者:
H. et al.
Awazu, M.: "The cyclin kinase inhibitor p27^<Kip1> is required for diabetic glomerular hypertrophy."J.Am.Soc.Nephrol.. 14. 699-799 (2003)
Awazu, M.:“糖尿病肾小球肥大需要细胞周期蛋白激酶抑制剂 p27^<Kip1>。”J.Am.Soc.Nephrol.. 14. 699-799 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hida, M.: "Eicosapentaenoic acid inhibits PDGF-induced mitogenesis and cyclin D1 expression via TGF-β in mesangial cells."J.Cell.Physiol.. 196. 293-300 (2003)
Hida, M.:“二十碳五烯酸通过 TGF-β 在系膜细胞中抑制 PDGF 诱导的有丝分裂和细胞周期蛋白 D1 表达。”J.Cell.Physiol.. 196. 293-300 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 65 条
DNA methylation and hydroxymethylation in the kidney from offspring of nutrient restricted rats
-
批准号:17K10152
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2017
-
负责人:AWAZU Midori
-
依托单位:
Mechanism of impaired nephrogeneis in intrauterine growth retardation and development of treatment strategies.
-
批准号:23591584
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:AWAZU Midori
-
依托单位:
The effects of maternal undernutrition and glucocorticoid on nephrogenesis
-
批准号:20591286
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:AWAZU Midori
-
依托单位:
Rele of MAP kinases in normal and abnormal renal development
-
批准号:10670757
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1998
-
负责人:AWAZU Midori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
载BFGF和SDF-1甲壳素水凝胶通过Sirt1/PINK1/parkin信号轴调控线粒体MAMs结构稳定性在SUI中的作用及机制
-
批准号:JCZRLH202602139
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
眼病精准诊疗技术与创新药物、装备研发及应用-治疗外伤性视神经病变的高负载bFGF水凝胶创新药物的研发
-
批准号:2025C02152
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:林丽
-
依托单位:
PRF牙髓血运重建术对年轻恒牙牙髓坏死患儿牙周龈沟液炎性因子、bFGF、VEGF水平和预后的影响
-
批准号:2025JJ80540
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:武甲子
-
依托单位:
基于Gas6/Axl信号轴调控铁死亡探索bFGF@adExos/GelMA复合水凝胶促脊髓损伤修复的研究
-
批准号:MS25H090029
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:汤呈宣
-
依托单位:
bFGF通过去泛素化酶USP37调控Keap1/Nrf2信号通路改善阿霉素诱导的心脏毒性的机制研究
-
批准号:2024Y9725
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:梅淋
-
依托单位:
定向移除伤口渗出液及缓释bFGF 的 Janus 敷
料对糖尿病足溃疡修复的研究
-
批准号:Q24H180035
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:罗玉婷
-
依托单位:
载 L-ZnO@bFGF 的单宁酸/季铵盐壳聚糖基多
功能可注射水凝胶促糖尿病感染创面修复性
能研究
-
批准号:TGY24H150023
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨虹
-
依托单位:
HA-bFGF/胶原蛋白复合水凝胶抑制METTL3介导的TM7SF2 m6A甲基化调控炎症和神经细胞增殖在脊髓损伤修复中的作用机制研究
-
批准号:2024Y9313
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:陈刚
-
依托单位:
机械响应性bFGF/壳聚糖水凝胶促进慢性鼓膜穿孔修复的作用及机制研究
-
批准号:LY23H130001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:沈毅
-
依托单位:
咪唑阳离子-bFGF聚离子液体透皮敷料通过改善局部微环境治疗糖尿病足的机制研究
-
批准号:82302811
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:董兴
-
依托单位: